Evaluation of a parallel plate membrane plasma exchange system.

Area of Science:

• Nephrology
• Immunology
• Biomedical Engineering

Background:

• Autoimmune diseases necessitate treatments like plasma exchange to remove harmful plasma components.
• Existing plasma exchange methods, such as centrifugal systems, may have limitations regarding efficiency and blood cell preservation.

Purpose of the Study:

• To evaluate the clinical efficacy and safety of a newly developed parallel plate membrane plasma exchange system.
• To assess the system's performance in removing plasma solutes and its impact on blood cell counts and complement activation.

Main Methods:

• Clinical evaluation of the Centry TPE System in 27 plasma exchange procedures on 14 patients with autoimmune diseases.
• Measurement of blood flow rates, plasma filtration rates, solute sieving coefficients, and reduction percentages.
• Analysis of blood cell counts (platelets) and complement activation (C'3 conversion).

Main Results:

• The system achieved nonselective plasma filtration with sieving coefficients around 1.00 for various solutes.
• An average reduction of 60-70% in plasma solutes was observed, consistent with theoretical predictions.
• No significant loss of blood cells was noted, unlike centrifugal systems which showed platelet reduction.
• Complement activation was undetectable or minimal, indicating a safe interaction with blood components.

Conclusions:

• The parallel plate membrane plasma exchange system is a safe and efficient method for treating autoimmune diseases.
• The system demonstrates effective solute removal while preserving blood cell integrity and minimizing adverse immunological reactions.
• This technology represents a promising advancement in therapeutic apheresis procedures.